# Ribogenics, Inc. — Form D

Ribogenics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-24. The offering totals $8.0M, of which $6.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-02-24
- Form: D
- Accession: 0001846802-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $6.0M
- Remaining: $2.0M
- Investors: 3
- Date of first sale: 2021-02-10
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-390403

## Issuer

- Name: Ribogenics, Inc.
- CIK: 0001846802
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: C/O SGRV P.C. 1635 MARKET STREET, PHILADELPHIA, PA, 19103
- Phone: 9194127411

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Laurent Arthaud | Director | Philadelphia, PA |
| Serge Braun | Director | Philadelphia, PA |
| Wei Zhang | Director | Hong Kong, K3 |
| Yves Ribeill | Executive Officer | Philadelphia, PA |

## More

- [CIK 1846802 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1846802&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001846802-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.